Loading...
Loading...

Go to the content (press return)

Peak bone mass in young HIV-infected patients compared with healthy controls

Author
Negredo, E.; Domingo, P.; Ferrer, E.; Perez, N.
Type of activity
Journal article
Journal
Journal of acquired immune deficiency syndromes
Date of publication
2014-02-01
Volume
65
Number
2
First page
207
Last page
212
DOI
https://doi.org/10.1097/01.qai.0000435598.20104.d6 Open in new window
Abstract
Introduction: Peak bone mass (PBM) is the amount of bone present at the end of skeletal maturation. It is an important determinant of osteoporotic fracture risk. Data on the PBM in the HIV-infected population are lacking. Design and Methods: We performed a multicenter (6 centers in Spain), case-control study to assess PBM using dual-energy x-ray absorptiometry. We studied HIV-infected patients aged 20-30 years and compared them with age- and gender-matched non-HIV-infected controls. We also asse...
Keywords
ACTIVE ANTIRETROVIRAL THERAPY, B LIGAND RANKL, FRACTURE RISK, HIV infection, LEAN MASS, MINERAL DENSITY, OSTEOPOROSIS, POPULATION, PREVALENCE, RANDOMIZED-TRIAL, TENOFOVIR, antiretroviral therapy, bone mineral density, osteoporosis, peak bone mass
Group of research
GRBIO - Biostatistics and Bioinformatics Research Group

Participants

  • Negredo Puigmal, Eugènia  (author)
  • Domingo, Pere L.  (author)
  • Ferrer Sistach, Elena  (author)
  • Perez Alvarez, Nuria  (author)